Regis Co. (NYSE:RGS) has been given a consensus recommendation of “Buy” by the six brokerages that are covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $18.00.

A number of research firms recently weighed in on RGS. Zacks Investment Research upgraded Regis from a “strong sell” rating to a “hold” rating in a report on Thursday, January 4th. KeyCorp began coverage on Regis in a report on Wednesday, December 20th. They issued a “sector weight” rating for the company. Finally, Jefferies Group increased their price objective on Regis from $17.00 to $18.00 and gave the company a “buy” rating in a report on Wednesday, November 1st.

A number of hedge funds and other institutional investors have recently bought and sold shares of RGS. Cramer Rosenthal Mcglynn LLC increased its holdings in Regis by 15.1% in the second quarter. Cramer Rosenthal Mcglynn LLC now owns 3,578,452 shares of the company’s stock valued at $36,751,000 after purchasing an additional 469,955 shares during the period. Northern Trust Corp grew its holdings in Regis by 84.5% during the 2nd quarter. Northern Trust Corp now owns 876,077 shares of the company’s stock worth $8,998,000 after acquiring an additional 401,194 shares during the period. Oaktree Capital Management LP acquired a new stake in Regis during the 3rd quarter worth about $4,593,000. Citadel Advisors LLC grew its holdings in Regis by 230.4% during the 2nd quarter. Citadel Advisors LLC now owns 307,170 shares of the company’s stock worth $3,154,000 after acquiring an additional 214,203 shares during the period. Finally, Renaissance Technologies LLC grew its holdings in Regis by 11.5% during the 2nd quarter. Renaissance Technologies LLC now owns 1,960,200 shares of the company’s stock worth $20,131,000 after acquiring an additional 202,700 shares during the period. Institutional investors and hedge funds own 95.55% of the company’s stock.

Regis (NYSE:RGS) traded up $0.08 during midday trading on Friday, reaching $15.53. The company had a trading volume of 73,595 shares, compared to its average volume of 95,436. The firm has a market capitalization of $722.03, a P/E ratio of -81.74, a price-to-earnings-growth ratio of 9.76 and a beta of 1.44. Regis has a 1-year low of $9.02 and a 1-year high of $16.68. The company has a quick ratio of 1.48, a current ratio of 1.94 and a debt-to-equity ratio of 0.25.

Regis (NYSE:RGS) last posted its quarterly earnings data on Tuesday, October 31st. The company reported $0.10 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.13 by ($0.03). The company had revenue of $309.87 million during the quarter, compared to analyst estimates of $334.10 million. Regis had a negative net margin of 2.70% and a positive return on equity of 0.81%. During the same quarter in the previous year, the company earned $0.12 earnings per share. sell-side analysts anticipate that Regis will post 0.22 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Brokerages Set Regis Co. (RGS) PT at $18.00” was reported by Daily Political and is the property of of Daily Political. If you are accessing this news story on another website, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this news story can be accessed at https://www.dailypolitical.com/2018/01/17/brokerages-set-regis-co-rgs-pt-at-18-00.html.

Regis Company Profile

Regis Corporation owns, franchises and operates beauty salons. The Company operates through two segments: North American Value and North American Premium. As of June 30, 2016, the Company’s North American Value salon operations consisted of 5,784 Company-owned salons and 2,496 franchised salons operating in the United States, Canada and Puerto Rico.

Receive News & Ratings for Regis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Regis and related companies with MarketBeat.com's FREE daily email newsletter.